Scarica l'app Stockscreener
1.02
0.00%
0.00
Dopo l'orario di chiusura:
1.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vivani Medical Inc Borsa (VANI) Ultime notizie
Vivani Medical Advances Drug Delivery Innovation with NanoPortal Technology - morgannewspaper.com
Vivani Medical's (VANI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Increases By 32.2% - MarketBeat
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - GlobeNewswire
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - Yahoo Finance
Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Acquires 34,000 Shares - MarketBeat
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com Australia
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com South Africa
Vivani medical director Gregg Williams buys $21,233 in stock - Investing.com
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Acquires 44,400 Shares of Stock - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical's director Gregg Williams acquires $205k in stock - Investing.com Australia
Vivani Medical’s director Gregg Williams acquires $205k in stock - Investing.com
Vivani Medical’s director Gregg Williams acquires $205k in stock By Investing.com - Investing.com South Africa
Vivani Medical's director Gregg Williams acquires $205k in stock By Investing.com - Investing.com India
Vivani Medical Director Gregg Williams Acquires Over 200K Shares - TradingView
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - MarketScreener
Vivani Medical (NASDAQ:VANI) Earns Buy Rating from HC Wainwright - Defense World
Vivani medical director Gregg Williams buys $24,959 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $24,959 in stock By Investing.com - Investing.com UK
Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m - simplywall.st
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target By Investing.com - Investing.com Canada
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target - Investing.com
Vivani Medical (NASDAQ:VANI) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Vivani medical chief business officer purchases $4,100 in shares By Investing.com - Investing.com South Africa
Vivani medical chief business officer purchases $4,100 in shares - Investing.com India
Vivani Medical’s Strategic Positioning and Promising Developments Earn a Buy Rating Despite Price Target Reduction - TipRanks
Vivani Medical: Q4 Earnings Snapshot - CT Insider
Vivani Medical Reports 2024 Financial Results and Business Progress - TipRanks
Vivani Medical Inc. (VANI) reports earnings - Quartz
Vivani Medical Advances with Successful Milestones in 2024 - TipRanks
Vivani Medical, Inc. SEC 10-K Report - TradingView
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
HC Wainwright Reaffirms Buy Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
1.75%
2.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):